株式会社グローバルインフォメーション
TEL: 044-952-0102
SALE
市場調査レポート

幹細胞療法の世界市場 - 予測と機会:2025年

Global Stem Cell Therapy Market By Type, By Source of Stem Cells, By Application, By End Users, By Region, Forecast & Opportunities, 2025

発行 TechSci Research 商品コード 934819
出版日 ページ情報 英文 118 Pages
納期: お問合せ
価格
本日の銀行送金レート: 1USD=108.69円で換算しております。

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

幹細胞療法の世界市場 - 予測と機会:2025年 Global Stem Cell Therapy Market By Type, By Source of Stem Cells, By Application, By End Users, By Region, Forecast & Opportunities, 2025
出版日: 2020年05月01日 ページ情報: 英文 118 Pages
概要

当レポートでは、世界の幹細胞療法市場について調査分析し、市場規模・シェア・予測、セグメント別分析、競合分析、市場動向の変化、新興の機会について、体系的な情報を提供しています。

目次

第1章 製品の概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の幹細胞療法市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 幹細胞の由来別
    • 用途別
    • エンドユーザー別
    • 企業別
    • 地域別
  • 製品市場マップ

第6章 アジア太平洋地域の幹細胞療法市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • アジア太平洋地域:国別分析

第7章 欧州の幹細胞療法市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • 欧州:国別分析

第8章 北米の幹細胞療法市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • 北米:国別分析

第9章 南米の幹細胞療法市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • 南米:国別分析

第10章 中東・アフリカの幹細胞療法市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • 中東・アフリカ:国別分析

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

第13章 競合情勢

第14章 戦略的提言

第15章 出版社と免責事項

目次
Product Code: 4488

Global stem cell therapy market is expected to grow at a formidable rate of around 12% during the forecast period. The global stem cell therapy market is driven by the growing popularity and awareness pertaining to the use of stem cells for the prevention and cure of certain life threatening diseases. Additionally, increase in number of stem cell banks and growing investments by the government and private organizations for the development of stem cell preservation infrastructure is further propelling the market across the globe.

The global stem cell therapy market is segmented based on type, source of stem cells, application, end users, company and region. Based on type, the market can be categorized into allogeneic, autologous and syngeneic. The allogenic type segment is expected to register the highest growth during forecast period attributable to the rising commercialization of allogeneic stem cell therapy products, wider therapeutic applications of allogeneic stem cells, easy production scale-up process, growing number of clinical trials related to allogeneic stem cell therapies, among others. Based on end users, the market can be bifurcated into hospitals and clinics. The hospitals segment is expected to dominate the market during the forecast years. This can be accredited to the rising preference for stem cell therapies offered by hospitals proves beneficial for the business growth. Hospitals have affiliations with research laboratories and academic institutes that carry out research activities for developing stem cell therapies. On introduction and approval of any novel stem therapy, hospitals implement it immediately.

Regionally, the stem cell therapy market has been segmented into various regions namely Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, North America is expected to dominate the overall stem cell therapy market during the next five years on account of the increasing number of clinical trials for stem cell-based products and increasing public-private funding & research grants.

Major players operating in the global stem cell therapy market include Osiris Therapeutics, Inc., MEDIPOST Co., Ltd., Anterogen Co., Ltd., Pharmicell Co., Ltd., Holostem Terapie Avanzate S.r.l., JCR Pharmaceuticals Co., Ltd., NuVasive, Inc., RTI Surgical, Inc., AlloSource, Thermo Fisher Scientific and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global stem cell therapy market.
  • To classify and forecast global stem cell therapy market based on type, source of stem cells, application, end users, company and regional distribution.
  • To identify drivers and challenges for global stem cell therapy market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global stem cell therapy market.
  • To identify and analyze the profile of leading players operating in global stem cell therapy market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics, end users, channels and presence of all major players across the globe.

TechSci Research calculated the market size of global stem cell therapy market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Stem Cell therapy hospitals, clinics and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to stem cell therapy
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals, clinics and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global stem cell therapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Type:

Allogeneic

Autologous

Syngeneic

  • Market, By Source of Stem Cells:

Adipose Tissue

Bone Marrow

Neural

Embryo/Cord Blood Derived

iPSCs

Others

  • Market, By Application:

Musculoskeletal

Wound & Injury

Cardiovascular Disease (CVD)

Surgery

Acute Graft-Versus-Host Disease

Drug Discovery & Development

Others

  • Market, By End Users:

Hospitals

Clinics

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global stem cell therapy market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Stem Cell Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Allogeneic, Autologous, Syngeneic)
    • 5.2.2. By Source of Stem Cells (Adipose Tissue, Bone Marrow, Neural, Embryo/Cord Blood Derived, iPSCs, Others)
    • 5.2.3. By Application (Musculoskeletal, Wound & Injury, Cardiovascular Disease (CVD), Surgery, Acute Graft-Versus-Host Disease, Drug Discovery & Development, Others)
    • 5.2.4. By End Users (Hospitals v/s Clinics)
    • 5.2.5. By Company (2019)
    • 5.2.6. By Region
  • 5.3. Product Market Map

6. Asia-Pacific Stem Cell Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Source of Stem Cells
    • 6.2.3. By Application
    • 6.2.4. By End Users
    • 6.2.5. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Stem Cell Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Source of Stem Cells
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End Users
    • 6.3.2. India Stem Cell Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Source of Stem Cells
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End Users
    • 6.3.3. Australia Stem Cell Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Source of Stem Cells
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End Users
    • 6.3.4. Japan Stem Cell Therapy Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type
        • 6.3.4.2.2. By Source of Stem Cells
        • 6.3.4.2.3. By Application
        • 6.3.4.2.4. By End Users
    • 6.3.5. South Korea Stem Cell Therapy Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type
        • 6.3.5.2.2. By Source of Stem Cells
        • 6.3.5.2.3. By Application
        • 6.3.5.2.4. By End Users

7. Europe Stem Cell Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Source of Stem Cells
    • 7.2.3. By Application
    • 7.2.4. By End Users
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Stem Cell Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Source of Stem Cells
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End Users
    • 7.3.2. Germany Stem Cell Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Source of Stem Cells
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End Users
    • 7.3.3. United Kingdom Stem Cell Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Source of Stem Cells
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End Users
    • 7.3.4. Italy Stem Cell Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Source of Stem Cells
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End Users
    • 7.3.5. Spain Stem Cell Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Source of Stem Cells
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End Users

8. North America Stem Cell Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Source of Stem Cells
    • 8.2.3. By Application
    • 8.2.4. By End Users
    • 8.2.5. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Stem Cell Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Source of Stem Cells
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End Users
    • 8.3.2. Mexico Stem Cell Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Source of Stem Cells
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End Users
    • 8.3.3. Canada Stem Cell Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Source of Stem Cells
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End Users

9. South America Stem Cell Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Source of Stem Cells
    • 9.2.3. By Application
    • 9.2.4. By End Users
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Stem Cell Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Source of Stem Cells
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End Users
    • 9.3.2. Argentina Stem Cell Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Source of Stem Cells
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End Users
    • 9.3.3. Colombia Stem Cell Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Source of Stem Cells
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End Users

10. Middle East and Africa Stem Cell Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Source of Stem Cells
    • 10.2.3. By Application
    • 10.2.4. By End Users
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Stem Cell Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Source of Stem Cells
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End Users
    • 10.3.2. Saudi Arabia Stem Cell Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Source of Stem Cells
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End Users
    • 10.3.3. UAE Stem Cell Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Source of Stem Cells
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End Users

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Osiris Therapeutics, Inc.
  • 13.2. MEDIPOST Co., Ltd.
  • 13.3. Anterogen Co., Ltd.
  • 13.4. Pharmicell Co., Ltd.
  • 13.5. Holostem Terapie Avanzate S.r.l.
  • 13.6. JCR Pharmaceuticals Co., Ltd.
  • 13.7. NuVasive, Inc.
  • 13.8. RTI Surgical, Inc.
  • 13.9. AlloSource
  • 13.10. Thermo Fisher Scientific

14. Strategic Recommendations

15. About Us & Disclaimer